Biheteroaryl inhibitors of farnesyl-protein transferase
US5854265A · kind A · utility
122Cited by
6References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 27, 1997 |
| Grant date | Dec 29, 1998 |
| Priority date | — |
| Expiry date | Mar 27, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.